An increasing number of Chinese pharmaceutical companies, in particular privately-owned firms in coastal areas, are eyeing the international market.

Domestic companies are working to counteract the on-going dumping claims. They understand that they might totally lose the target market if they do not respond.

Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.

Global demand for China's pharmaceuticals is strong.